Allergy and Infectious Diseases Research in District of Columbia
Allergy and Infectious Diseases Research (93.855) awarded $118 million to recipients in District of Columbia in 80 grants from fiscal 2021 to 2025, 0.5% of the program's national total. George Washington University (the) received the most, $76.8 million.
- Awarded in District of Columbia$118 million
- Awards80
- Share of the program0.5%
- Rank among states28th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 36 | $21.9 million |
| FY 2022 | 37 | $22.6 million |
| FY 2023 | 39 | $21.8 million |
| FY 2024 | 43 | $25.6 million |
| FY 2025 | 34 | $26.6 million |
Recipients in District of Columbia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| George Washington University (the) | Colleges and universities | 35 | $76.8 million |
| Georgetown University | Colleges and universities | 23 | $17.3 million |
| Children's Research Institute | Nonprofits | 9 | $12.5 million |
| Whitman-Walker Institute Inc | Nonprofits | 2 | $4.4 million |
| Carnegie Institution of Washington | Nonprofits | 2 | $3.6 million |
| Catholic University of America (the) | Colleges and universities | 1 | $1.4 million |
| Howard University | Colleges and universities | 3 | $1.2 million |
| American Society for Microbiology | Nonprofits | 2 | $806,006 |
| American University | Colleges and universities | 1 | $286,070 |
| Ias | Nonprofits | 2 | $175,000 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to District of Columbia?
$118 million from fiscal 2021 to 2025, across 80 awards. District of Columbia ranks 28th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in District of Columbia?
The largest recipient is George Washington University (the), with $76.8 million in 35 awards. Next are Georgetown University and Children's Research Institute.
Can organizations in District of Columbia apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in District of Columbia
- National Railroad Passenger Corporation Grants
- Grants to States for Medicaid
- USAID Foreign Assistance for Programs Overseas
- Federal-State Partnership for Intercity Passenger Rail
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Federal Transit Formula Grants
- International Programs to Support Democracy, Human Rights and Labor
- Environmental and Scientific Partnerships and Programs
- International Broadcasting Independent Grantee Organizations
- Highway Planning and Construction